{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T03:16:10Z","timestamp":1794280570117,"version":"4.9.0"},"reference-count":37,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82471226"],"award-info":[{"award-number":["82471226"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100016086","name":"Key Laboratory in Science and Technology Development Project of Suzhou","doi-asserted-by":"publisher","award":["SKY2023180"],"award-info":[{"award-number":["SKY2023180"]}],"id":[{"id":"10.13039\/100016086","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100014358","name":"Second Affiliated Hospital of Soochow University","doi-asserted-by":"publisher","award":["ND2023B06"],"award-info":[{"award-number":["ND2023B06"]}],"id":[{"id":"10.13039\/501100014358","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Neurology and Neurosurgery"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1016\/j.clineuro.2025.109038","type":"journal-article","created":{"date-parts":[[2025,7,3]],"date-time":"2025-07-03T10:10:17Z","timestamp":1751537417000},"page":"109038","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Short-term outcomes of intravenous tenecteplase compared with alteplase for mild acute ischemic stroke"],"prefix":"10.1016","volume":"257","author":[{"given":"Yan","family":"Qin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Longhai","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoting","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tingting","family":"Kang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongjun","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tao","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3852-3993","authenticated-orcid":false,"given":"Jijun","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clineuro.2025.109038_bib1","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1001\/jamaneurol.2019.5061","article-title":"Distributional validity and prognostic power of the national institutes of health stroke scale in US administrative claims data","volume":"77","author":"Saber","year":"2020","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.clineuro.2025.109038_bib2","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1161\/STROKEAHA.120.031329","article-title":"Clinical characteristics and in-hospital outcomes of varying definitions of minor stroke: from a large-scale nation-wide longitudinal registry","volume":"52","author":"Xiong","year":"2021","journal-title":"Stroke"},{"key":"10.1016\/j.clineuro.2025.109038_bib3","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1136\/svn-2019-000242","article-title":"The Third China National Stroke Registry (CNSR-III) for patients with acute ischaemic stroke or transient ischaemic attack: design, rationale and baseline patient characteristics","volume":"4","author":"Wang","year":"2019","journal-title":"Stroke Vasc. Neurol."},{"key":"10.1016\/j.clineuro.2025.109038_bib4","doi-asserted-by":"crossref","DOI":"10.1001\/jamaneurol.2024.0146","article-title":"Clopidogrel plus aspirin vs aspirin alone in patients with acute mild to moderate stroke: the ATAMIS randomized clinical trial","author":"Chen","year":"2024","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.clineuro.2025.109038_bib5","doi-asserted-by":"crossref","first-page":"2308","DOI":"10.1111\/cns.14164","article-title":"Outcomes in minor stroke patients treated with intravenous thrombolysis","volume":"29","author":"Duan","year":"2023","journal-title":"CNS Neurosci. Ther."},{"key":"10.1016\/j.clineuro.2025.109038_bib6","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1001\/jama.2018.8496","article-title":"Effect of alteplase vs aspirin on functional outcome for patients with acute ischemic stroke and minor nondisabling neurologic deficits: the PRISMS randomized clinical trial","volume":"320","author":"Khatri","year":"2018","journal-title":"JAMA"},{"key":"10.1016\/j.clineuro.2025.109038_bib7","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1161\/STROKEAHA.123.045495","article-title":"Intravenous alteplase versus best medical therapy for patients with minor stroke: a systematic review and meta-analysis","volume":"55","author":"Zhang","year":"2024","journal-title":"Stroke"},{"key":"10.1016\/j.clineuro.2025.109038_bib8","doi-asserted-by":"crossref","first-page":"JC110","DOI":"10.7326\/J23-0072","article-title":"In minor, nondisabling, acute ischemic stroke, DAPT was noninferior to IV alteplase for excellent functional outcome at 90 d","volume":"176","author":"Eastin","year":"2023","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.clineuro.2025.109038_bib9","doi-asserted-by":"crossref","DOI":"10.1002\/brb3.1210","article-title":"The rate of early neurological deterioration occurring after thrombolytic therapy: a meta-analysis","volume":"9","author":"Hou","year":"2019","journal-title":"Brain Behav."},{"key":"10.1016\/j.clineuro.2025.109038_bib10","doi-asserted-by":"crossref","first-page":"2135","DOI":"10.1001\/jama.2023.7827","article-title":"Dual antiplatelet therapy vs alteplase for patients with minor nondisabling acute ischemic stroke: the ARAMIS randomized clinical trial","volume":"329","author":"Chen","year":"2023","journal-title":"JAMA"},{"key":"10.1016\/j.clineuro.2025.109038_bib11","doi-asserted-by":"crossref","DOI":"10.1001\/jama.2024.14721","article-title":"Tenecteplase vs alteplase for patients with acute ischemic stroke: the ORIGINAL randomized clinical trial","author":"Meng","year":"2024","journal-title":"JAMA"},{"key":"10.1016\/j.clineuro.2025.109038_bib12","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/S0140-6736(22)02600-9","article-title":"Tenecteplase versus alteplase in acute ischaemic cerebrovascular events (TRACE-2): a phase 3, multicentre, open-label, randomised controlled, non-inferiority trial","volume":"401","author":"Wang","year":"2023","journal-title":"Lancet"},{"key":"10.1016\/j.clineuro.2025.109038_bib13","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1001\/jamaneurol.2023.2094","article-title":"Safety and efficacy of tenecteplase compared with alteplase in patients with large vessel occlusion stroke: a prespecified secondary analysis of the ACT randomized clinical trial","volume":"80","author":"Bala","year":"2023","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.clineuro.2025.109038_bib14","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/S0140-6736(22)01054-6","article-title":"Intravenous tenecteplase compared with alteplase for acute ischaemic stroke in Canada (AcT): a pragmatic, multicentre, open-label, registry-linked, randomised, controlled, non-inferiority trial","volume":"400","author":"Menon","year":"2022","journal-title":"Lancet"},{"key":"10.1016\/j.clineuro.2025.109038_bib15","doi-asserted-by":"crossref","DOI":"10.1212\/WNL.0000000000209903","article-title":"Tenecteplase vs alteplase in acute ischemic stroke within 4.5\u2009h: a systematic review and meta-analysis of randomized trials","volume":"103","author":"Palaiodimou","year":"2024","journal-title":"Neurology"},{"key":"10.1016\/j.clineuro.2025.109038_bib16","doi-asserted-by":"crossref","first-page":"2597","DOI":"10.1016\/S0140-6736(24)00921-8","article-title":"Tenecteplase versus standard of care for minor ischaemic stroke with proven occlusion (TEMPO-2): a randomised, open label, phase 3 superiority trial","volume":"403","author":"Coutts","year":"2024","journal-title":"Lancet"},{"key":"10.1016\/j.clineuro.2025.109038_bib17","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1016\/S1474-4422(24)00377-6","article-title":"Tenecteplase versus alteplase for acute stroke within 4.5\u2009h of onset (ATTEST-2): a randomised, parallel group, open-label trial","volume":"23","author":"Muir","year":"2024","journal-title":"Lancet Neurol."},{"issue":"3","key":"10.1016\/j.clineuro.2025.109038_bib18","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2025.0548","article-title":"Short-term safety and effectiveness for tenecteplase and alteplase in acute ischemic stroke","volume":"8","author":"Rousseau","year":"2025","journal-title":"JAMA Netw. Open"},{"key":"10.1016\/j.clineuro.2025.109038_bib19","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1161\/STROKEAHA.118.024223","article-title":"Tenecteplase versus alteplase between 3 and 4.5\u2009h in low national institutes of health stroke scale","volume":"50","author":"R\u00f8nning","year":"2019","journal-title":"Stroke"},{"key":"10.1016\/j.clineuro.2025.109038_bib20","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1001\/jamaneurol.2014.4354","article-title":"Outcomes in mild acute ischemic stroke treated with intravenous thrombolysis: a retrospective analysis of the get with the guidelines-stroke registry","volume":"72","author":"Romano","year":"2015","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.clineuro.2025.109038_bib21","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/s12883-024-04000-8","article-title":"Safety and efficacy of intravenous thrombolysis: a systematic review and meta-analysis of 93,057 minor stroke patients","volume":"25","author":"Moawad","year":"2025","journal-title":"BMC Neurol."},{"key":"10.1016\/j.clineuro.2025.109038_bib22","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1161\/STROKEAHA.119.027476","article-title":"Redefined measure of early neurological improvement shows treatment benefit of alteplase over placebo","volume":"51","author":"Agarwal","year":"2020","journal-title":"Stroke"},{"key":"10.1016\/j.clineuro.2025.109038_bib23","doi-asserted-by":"crossref","first-page":"e1437","DOI":"10.1212\/WNL.0000000000012661","article-title":"Early neurologic deterioration in lacunar stroke: clinical and imaging predictors and association with long-term outcome","volume":"97","author":"Vynckier","year":"2021","journal-title":"Neurology"},{"key":"10.1016\/j.clineuro.2025.109038_bib24","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1016\/S1474-4422(17)30253-3","article-title":"Tenecteplase versus alteplase for management of acute ischaemic stroke (NOR-TEST): a phase 3, randomised, open-label, blinded endpoint trial","volume":"16","author":"Logallo","year":"2017","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.clineuro.2025.109038_bib25","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1056\/NEJMoa1716405","article-title":"Tenecteplase versus alteplase before thrombectomy for ischemic stroke","volume":"378","author":"Campbell","year":"2018","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.clineuro.2025.109038_bib26","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1001\/jama.2020.1511","article-title":"Effect of intravenous tenecteplase dose on cerebral reperfusion before thrombectomy in patients with large vessel occlusion ischemic stroke: the EXTEND-IA TNK part 2 randomized clinical trial","volume":"323","author":"Campbell","year":"2020","journal-title":"JAMA"},{"key":"10.1016\/j.clineuro.2025.109038_bib27","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1161\/STROKEAHA.120.030220","article-title":"Intravenous thrombolysis with tenecteplase in patients with large vessel occlusions: systematic review and meta-analysis","volume":"52","author":"Katsanos","year":"2021","journal-title":"Stroke"},{"key":"10.1016\/j.clineuro.2025.109038_bib28","article-title":"Characteristics, temporal trends and outcomes of intravenous thrombolysis in chinese patients aged > 80 years who had a stroke","author":"Li","year":"2024","journal-title":"Stroke Vasc. Neurol."},{"key":"10.1016\/j.clineuro.2025.109038_bib29","article-title":"Tenecteplase thrombolytic therapy for acute ischaemic stroke in china: a real-world, multicentre, retrospective, controlled study","author":"Liu","year":"2024","journal-title":"Stroke Vasc. Neurol."},{"key":"10.1016\/j.clineuro.2025.109038_bib30","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1007\/s11239-018-1721-3","article-title":"Tenecteplase versus alteplase for management of acute ischemic stroke: a pairwise and network meta-analysis of randomized clinical trials","volume":"46","author":"Kheiri","year":"2018","journal-title":"J. Thromb. Thrombolysis"},{"key":"10.1016\/j.clineuro.2025.109038_bib31","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1161\/CIRCULATIONAHA.123.064053","article-title":"Shorter door-to-needle times are associated with better outcomes after intravenous thrombolytic therapy and endovascular thrombectomy for acute ischemic stroke","volume":"148","author":"Man","year":"2023","journal-title":"Circulation"},{"key":"10.1016\/j.clineuro.2025.109038_bib32","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1136\/svn-2017-000074","article-title":"The Chinese Stroke Association scientific statement: intravenous thrombolysis in acute ischaemic stroke","volume":"2","author":"Dong","year":"2017","journal-title":"Stroke Vasc. Neurol."},{"key":"10.1016\/j.clineuro.2025.109038_bib33","doi-asserted-by":"crossref","first-page":"e344","DOI":"10.1161\/STROKEAHA.118.022606","volume":"50","author":"Powers","year":"2019","journal-title":"Stroke"},{"key":"10.1016\/j.clineuro.2025.109038_bib34","doi-asserted-by":"crossref","first-page":"I","DOI":"10.1177\/2396987321989865","article-title":"European stroke organisation (ESO) guidelines on intravenous thrombolysis for acute ischaemic stroke","volume":"6","author":"Berge","year":"2021","journal-title":"Eur. Stroke J."},{"key":"10.1016\/j.clineuro.2025.109038_bib35","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2022.4506","article-title":"Off-label use of tenecteplase for the treatment of acute ischemic stroke: a systematic review and meta-analysis","volume":"5","author":"Katsanos","year":"2022","journal-title":"JAMA Netw. Open"},{"key":"10.1016\/j.clineuro.2025.109038_bib36","doi-asserted-by":"crossref","first-page":"2156","DOI":"10.1161\/STROKEAHA.119.025080","article-title":"Evidence that tenecteplase is noninferior to alteplase for acute ischemic stroke: meta-analysis of 5 randomized trials","volume":"50","author":"Burgos","year":"2019","journal-title":"Stroke"},{"key":"10.1016\/j.clineuro.2025.109038_bib37","doi-asserted-by":"crossref","first-page":"2766","DOI":"10.1161\/STROKEAHA.123.044267","article-title":"Effect of time to thrombolysis on clinical outcomes in patients with acute ischemic stroke treated with tenecteplase compared to alteplase: analysis from the AcT randomized controlled trial","volume":"54","author":"Singh","year":"2023","journal-title":"Stroke"}],"container-title":["Clinical Neurology and Neurosurgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S030384672500321X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S030384672500321X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,4]],"date-time":"2025-11-04T20:33:25Z","timestamp":1762288405000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S030384672500321X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10]]},"references-count":37,"alternative-id":["S030384672500321X"],"URL":"https:\/\/doi.org\/10.1016\/j.clineuro.2025.109038","relation":{},"ISSN":["0303-8467"],"issn-type":[{"value":"0303-8467","type":"print"}],"subject":[],"published":{"date-parts":[[2025,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Short-term outcomes of intravenous tenecteplase compared with alteplase for mild acute ischemic stroke","name":"articletitle","label":"Article Title"},{"value":"Clinical Neurology and Neurosurgery","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clineuro.2025.109038","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"109038"}}